Quarterly report [Sections 13 or 15(d)]

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net increase (decrease) in net assets from operations $ 998,809 $ (6,894,707)
Adjustments to reconcile net increase (decrease) in net assets to net cash (used in) provided by operating activities:    
Investments in portfolio companies (12,027,924) (409,755)
Proceeds from sale of portfolio investments 2,278,519 955,357
Proceeds from loan repayments 1,750,000 8,490,868
Net realized gain on sales and dispositions of portfolio investments (2,034,519) (925,332)
Change in unrealized appreciation/depreciation on investments 2,377,667 11,610,598
Deferred income tax benefit 0 (109,277)
Amortization 12,500 12,500
Original issue discount amortization (4,200) (29,004)
Non-cash conversion of debenture interest (359,953) (1,223,945)
Non-cash conversion of loan modification fee 0 (15,000)
Change in interest receivable allowance 0 25,337
Changes in operating assets and liabilities:    
(Increase) decrease in interest receivable (63,153) 81,930
Increase in other assets (129,093) (46,045)
Increase in prepaid income taxes (44,507) (15,330)
Decrease in accounts payable and accrued expenses (16,400) (53,968)
Increase (decrease) in due to investment adviser 28,762 (1,673,346)
Decrease in capital gains incentive fees payable 0 (1,565,000)
Increase (decrease) in deferred revenue 76,558 (138,956)
Total adjustments (8,155,743) 14,971,632
Net cash (used in) provided by operating activities (7,156,934) 8,076,925
Cash flows from financing activities:    
Net proceeds from (repayment of) line of credit 5,100,000 (600,000)
Payment of cash dividend (1,722,375) (3,891,917)
Net cash provided by (used in) financing activities 3,377,625 (4,491,917)
Net (decrease) increase in cash and cash equivalents (3,779,309) 3,585,008
Cash and cash equivalents:    
Beginning of period 4,208,948 834,805
End of period $ 429,639 $ 4,419,813